Libert(SH:605167) Tianfeng Securities·2025-05-01 09:48Investment Rating - The investment rating for the company is "Buy" with a target price not specified [6]. Core Views - The company has shown stable profitability, with a slight increase in non-recurring profit in Q1, and a positive outlook for medium to long-term development [1]. - The revenue from modular design and manufacturing is rapidly increasing, contributing to further improvements in gross margin [2]. - The company is utilizing convertible bonds to fund a large industrial module project, which is expected to enhance its manufacturing capabilities and efficiency [4]. Financial Performance Summary - In Q1, the company achieved revenue of 668 million, a year-on-year increase of 1.45%, with a net profit attributable to the parent company of 36 million, down 8.07% year-on-year [1]. - For 2024, the company is projected to achieve revenue of 3.493 billion, a year-on-year increase of 7.72%, and a net profit of 240 million, up 26.45% year-on-year [1][5]. - The gross margin for 2024 is expected to be 16.1%, an increase of 1.55 percentage points year-on-year [2]. Revenue Breakdown - In 2024, the revenue from industrial module design and manufacturing is expected to reach 724 million, a year-on-year increase of 46.36%, while engineering services are projected to generate 2.76 billion, a slight increase of 0.73% [2]. - Domestic sales are projected to be 3.083 billion, up 3.67% year-on-year, while export sales are expected to reach 401 million, a significant increase of 53.6% [2]. Cost and Cash Flow Analysis - The company's expense ratio for 2024 is projected to be 7.18%, an increase of 0.89 percentage points year-on-year, with net profit margin expected to be 6.89% [3]. - The cash flow from operations for 2024 is expected to be 415 million, an increase of 64 million year-on-year, indicating a strong cash flow situation [3]. Future Projections - The company is expected to achieve net profits of 280 million, 320 million, and 370 million for the years 2025 to 2027, respectively, with corresponding P/E ratios of 14, 12, and 11 [4].